Undervalued Drug Manufacturer Stocks on TSE July 2025

July 19, 2025

Drug Manufacturers

Drug Manufacturers are engaged in pharmaceutical manufacturing or sale of a diverse line of drug and healthcare products. This industry group also includes companies engaged in the development and discovery of new dugs, and tobacco and cannabis companies.

Toronto Stock Exchange

The Toronto Stock Exchange (TSE) is a stock exchange located in Toronto, Ontario, Canada. It is the 10th largest exchange in the world and the third largest in North America based on market capitalization.

Our Valuation

A stock is considered undervalued if it trades at a discount to our valuation. To determine a stock’s intrinsic value, we developed an algorithm that uses 6 valuation models to determine the value of a company.* To learn more about stockcalc’s valuation methods, click here.

Undervalued Drug Manufacturers stocks

Stocks in this category are held primarily for potential income and capital appreciation.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose Price ($)Valuation ($)Difference (%)Average Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
TLRY Tilray Brands 0.59 1.39 135.41 1260517 536 0.00 0.0
TSND TerrAscend 0.49 1.01 105.37 118262 144 0.00 35.4
CURA Curaleaf Holdings 1.14 1.94 70.43 346956 849 0.00 0.0
AVNT Avant Brands 0.82 1.24 50.89 3669 9 0.00 0.0
WEED Canopy Gwth 1.80 2.70 49.86 2232534 199 0.00 0.0
OGI Organigram Global 1.83 2.73 48.91 161076 244 0.00 10.5
ACB Aurora Cannabis 7.27 9.38 29.03 382748 405 0.00 26.9
CWEB Charlottes Web Holdings 0.14 0.18 28.77 34459 22 0.00 0.0
MDP Medexus Pharma 3.08 3.87 25.79 27876 76 0.00 14.8
DHT.U DRI Healthcare Trust 9.10 11.04 21.31 33 512 3.90 303.3
All data provided as at market close May 29, 2025.

Company Details

Tilray Brands

TLRY:TSX

Close Price

0.59

Our Valuation

1.39

% Difference

135.41

Market Cap ($M)

536

P/E Ratio

0.0

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.

Access the stockcalc valuation


TerrAscend

TSND:TSX

Close Price

0.49

Our Valuation

1.01

% Difference

105.37

Market Cap ($M)

144

P/E Ratio

35.4

TerrAscend Corp is a company focused on creating and delivering quality cannabis products and services that meet the evolving needs of its patients. It also provides education and support programs to physicians and patients through healthcare professionals. In addition, the Company has retail operations in Ontario, Canada, with a majority-owned dispensary in Toronto, Ontario, Canada.

Access the stockcalc valuation


Curaleaf Holdings

CURA:TSX

Close Price

1.14

Our Valuation

1.94

% Difference

70.43

Market Cap ($M)

849

P/E Ratio

0.0

Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the US. The company has operations in 17 states. Its brands include Curaleaf, Select, and Grassroots. The company has made acquisitions that give it exposure to the growing European market, a unique feature among US multistate operators.

Access the stockcalc valuation


Avant Brands

AVNT:TSX

Close Price

0.82

Our Valuation

1.24

% Difference

50.89

Market Cap ($M)

9

P/E Ratio

0.0

Avant Brands Inc is a premium cannabis company. It has multiple licensed and operational production facilities across Canada, which produce high-quality, handcrafted cannabis products for desired, and award-winning consumer brands, sold across both recreational and medical channels. The company's diverse product range is distributed through three distinct sales channels: recreational, medical, and export.

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

Canopy Gwth

WEED:TSX

Close Price

1.80

Our Valuation

2.70

% Difference

49.86

Market Cap ($M)

199

P/E Ratio

0.0

Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include skincare products under Martha Stewart CBD and Storz & Bickel vaporizers. Canopy growth merged its US assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.

Access the stockcalc valuation


Organigram Global

OGI:TSX

Close Price

1.83

Our Valuation

2.73

% Difference

48.91

Market Cap ($M)

244

P/E Ratio

10.5

Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK.

Access the stockcalc valuation


Aurora Cannabis

ACB:TSX

Close Price

7.27

Our Valuation

9.38

% Difference

29.03

Market Cap ($M)

405

P/E Ratio

26.9

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements.

Access the stockcalc valuation


Charlottes Web Holdings

CWEB:TSX

Close Price

0.14

Our Valuation

0.18

% Difference

28.77

Market Cap ($M)

22

P/E Ratio

0.0

Charlottes Web Holdings Inc is engaged in the production and distribution of hemp-based cannabidiol (CBD) wellness products. Its product categories include ingestible products (tinctures, capsules, and gummies), topicals, and pet products. The company distributes its products through an e-commerce website, third-party e-commerce websites, select distributors, health practitioners, and a variety of brick-and-mortar specialty retailers.

Access the stockcalc valuation


Medexus Pharma

MDP:TSX

Close Price

3.08

Our Valuation

3.87

% Difference

25.79

Market Cap ($M)

76

P/E Ratio

14.8

Medexus Pharmaceuticals Inc is a specialty pharmaceutical company with a powerful North American commercial platform and a growing portfolio of inventive and rare disease treatment solutions. The company's focus is on the therapeutic areas of oncology, hematology, rheumatology, auto-immune diseases, allergy, and dermatology.

Access the stockcalc valuation


DRI Healthcare Trust

DHT.U:TSX

Close Price

9.10

Our Valuation

11.04

% Difference

21.31

Market Cap ($M)

512

P/E Ratio

303.3

DRI Healthcare Trust is engaged in pharmaceutical royalty monetization by providing capital to inventors, academic institutions, and biopharma companies. Trust was formed to provide Unitholders with differential exposure to the pharmaceutical and biotechnology industries through ownership and acquisitions of pharmaceutical royalties.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
Tilray Brands and TerrAscend are the most undervalued Drug Manufacturers stocks on the TSE. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-drug-manufacturer-stocks-tse-july-2025
Tilray Brands $TLRY and TerrAscend $TSND are the most undervalued Drug Manufacturers stocks on the #TSE. See the full list: https://www.stockcalc.com/Blog/undervalued-drug-manufacturer-stocks-tse-july-2025
Tilray Brands and TerrAscend are the most undervalued Drug Manufacturers stocks on the TSE. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-drug-manufacturer-stocks-tse-july-2025

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.